medmix AG Market Cap ($352.23 Million)
Market Cap & Net Worth: medmix AG (MEDX)
medmix AG market cap. medmix AG (SW:MEDX) has a market capitalization of $352.23 Million (CHF278.60 Million) as of November 5, 2026. Listed on the SW stock exchange, this Switzerland-based company holds position #13783 globally and #150 in its home market, demonstrating a 5.74% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying medmix AG's stock price CHF11.06 by its total outstanding shares 40672909 (40.67 Million). Also see cash flow conversion of medmix AG for how efficiently the company converts equity into cash flow.
medmix AG Market Cap History (2021–2026)
medmix AG market cap history from 2021 to 2026. Data shows change from $2.16 Billion to $568.72 Million (-22.65% CAGR). Check MEDX share price today for real-time trading data and today's change.
medmix AG Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how medmix AG's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore MEDX year-over-year net asset growth to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
1.29x
medmix AG's market cap is 1.29 times its annual revenue
Latest Price to Earnings (P/E) Ratio
90.31x
medmix AG's market cap is 90.31 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $2.16 Billion | $457.30 Million | $44.00 Million | 4.73x | 49.14x |
| 2022 | $855.34 Million | $477.10 Million | $11.60 Million | 1.79x | 73.74x |
| 2023 | $945.58 Million | $486.60 Million | $300.00K | 1.94x | 3151.92x |
| 2024 | $452.51 Million | $483.90 Million | -$7.40 Million | 0.94x | N/A |
| 2025 | $577.98 Million | $448.00 Million | $6.40 Million | 1.29x | 90.31x |
Competitor Companies of MEDX by Market Capitalization
Companies near medmix AG in the global market cap rankings as of November 5, 2026. Also see medmix AG (MEDX) total assets for a full breakdown of the balance sheet.
Key companies related to medmix AG by market ranking:
- GE Vernova LLC (NYSE:GEV): Ranked #88 globally with a market cap of $223.80 Billion USD.
- Siemens Aktiengesellschaft (XETRA:SIE): Ranked #91 globally with a market cap of $218.11 Billion USD ( €186.56 Billion EUR).
- SIEMENS AG SP. ADR 1/ 1/2 (F:SIEB): Ranked #124 globally with a market cap of $177.31 Billion USD ( €151.67 Billion EUR).
- Schneider Electric S.E. (PA:SU): Ranked #152 globally with a market cap of $152.50 Billion USD ( €130.44 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #88 | GE Vernova LLC | NYSE:GEV | $223.80 Billion | $832.83 |
| #91 | Siemens Aktiengesellschaft | XETRA:SIE | $218.11 Billion | €275.65 |
| #124 | SIEMENS AG SP. ADR 1/ 1/2 | F:SIEB | $177.31 Billion | €119.00 |
| #152 | Schneider Electric S.E. | PA:SU | $152.50 Billion | €231.55 |
Market Capitalization of medmix AG (2021–2026)
Market capitalization of medmix AG from 2021 to today. Between 2021 and today, medmix AG's market cap moved from $2.16 Billion to $ 568.72 Million, with a yearly change of -22.65%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CHF568.72 Million | -1.60% |
| 2025 | CHF577.98 Million | +27.73% |
| 2024 | CHF452.51 Million | -52.14% |
| 2023 | CHF945.58 Million | +10.55% |
| 2022 | CHF855.34 Million | -60.44% |
| 2021 | CHF2.16 Billion | -- |
End of Day Market Cap According to Different Sources
On Nov 5th, 2026 the market cap of medmix AG was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $352.23 Million USD |
| MoneyControl | $352.23 Million USD |
| MarketWatch | $352.23 Million USD |
| marketcap.company | $352.23 Million USD |
| Reuters | $352.23 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About medmix AG
medmix AG designs, produces, and sells high-precision devices and services in Switzerland and internationally. It operates through the Healthcare, and Consumer and Industrial segments. The company offers dispensers, cartridges, mixers, tips, syringes, pen, and auto injectors for delivery of dental materials; delivery devices and mixing for bone repair and tissue treatment, which are used for pros… Read more